Concepedia

Takushi Kaneko

TK

Statistics

Publications

43

Citations

2.9K

H-Index

29

Active since

1973

Affiliations

Pfizer (United States)(Current)

Bristol-Myers Squibb (United States)

TB Alliance

Bristol-Myers Squibb (Germany)

University of Illinois Chicago

Takushi Kaneko is an author at Pfizer (United States) specializing in drug discovery, pharmacology, and medicinal chemistry.

Publications per year

1973–2023

43

Publications

43

Sphingobacterium gen. nov., Sphingobacterium spiritivorum comb. nov., Sphingobacterium multivorum comb. nov., Sphingobacterium mizutae sp. nov., and Flavobacterium indologenes sp. nov.: Glucose-Nonfermenting Gram-Negative Rods in CDC Groups IIK-2 and IIb

Eiko Yabuuchi, Takushi Kaneko, Ikuya Yano et al. · International Journal of Systematic Bacteriology · 1983 · 289 citations

, , +11

Identification of a small molecule with activity against drug-resistant and persistent tuberculosis

Feng Wang, Dhinakaran Sambandan, Rajkumar Halder et al. · Proceedings of the National Academy of Sciences · 2013 · 226 citations · Full text

, , +17

(6-Maleimidocaproyl)hydrazone of doxorubicin. A new derivative for the preparation of immunoconjugates of doxorubicin

David Willner, Pamela A. Trail, Sandra J. Hofstead et al. · Bioconjugate Chemistry · 1993 · 222 citations

, , +17

Evaluation in vitro of adriamycin immunoconjugates synthesized using an acid-sensitive hydrazone linker.

Robert S. Greenfield, Takushi Kaneko, A Daues et al. · PubMed · 1990 · 179 citations

, , +17

New hydrazone derivatives of Adriamycin and their immunoconjugates - a correlation between acid stability and cytotoxicity

Takushi Kaneko, David Willner, Ivo Monković et al. · Bioconjugate Chemistry · 1991 · 162 citations

, , +9

1–5 of 43